- Home
- AREB vs CNSP Comparison
AREB vs CNSP Comparison
Compare AREB & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AREB
- CNSP
- Stock Information
- Founded
- AREB 2014
- CNSP 2017
- Country
- AREB United States
- CNSP United States
- Employees
- AREB N/A
- CNSP N/A
- Industry
- AREB Plastic Products
- CNSP Biotechnology: Pharmaceutical Preparations
- Sector
- AREB Industrials
- CNSP Health Care
- Exchange
- AREB Nasdaq
- CNSP Nasdaq
- Market Cap
- AREB 5.7M
- CNSP 5.6M
- IPO Year
- AREB N/A
- CNSP 2019
- Fundamental
- Price
- AREB $1.40
- CNSP $1.03
- Analyst Decision
- AREB
- CNSP Hold
- Analyst Count
- AREB 0
- CNSP 1
- Target Price
- AREB N/A
- CNSP N/A
- AVG Volume (30 Days)
- AREB 2.4M
- CNSP 4.9M
- Earning Date
- AREB 05-15-2025
- CNSP 05-16-2025
- Dividend Yield
- AREB N/A
- CNSP N/A
- EPS Growth
- AREB N/A
- CNSP N/A
- EPS
- AREB N/A
- CNSP N/A
- Revenue
- AREB $9,887,755.00
- CNSP N/A
- Revenue This Year
- AREB N/A
- CNSP N/A
- Revenue Next Year
- AREB N/A
- CNSP N/A
- P/E Ratio
- AREB N/A
- CNSP N/A
- Revenue Growth
- AREB N/A
- CNSP N/A
- 52 Week Low
- AREB $1.10
- CNSP $0.77
- 52 Week High
- AREB $231.75
- CNSP $620.00
- Technical
- Relative Strength Index (RSI)
- AREB 34.65
- CNSP 39.21
- Support Level
- AREB $2.20
- CNSP $1.04
- Resistance Level
- AREB $3.05
- CNSP $1.38
- Average True Range (ATR)
- AREB 0.25
- CNSP 0.23
- MACD
- AREB 0.07
- CNSP 0.00
- Stochastic Oscillator
- AREB 1.20
- CNSP 0.00
About AREB American Rebel Holdings Inc.
American Rebel Holdings Inc develops self-defense, safe storage, and patriotic product areas using a wholesale distribution network, utilizing personal appearances, musical venue performances, as well as e-commerce and television. It designs, manufactures, and markets concealed carry products. It offers products ranging in Backpacks, jackets, coats, and Others. The Company views its operations and manages its business as one operating segment engaged in patriotic goods, comprised of safes, soft goods, and beer.
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.